Synopsis
Laryngeal and hypopharyngeal cancers have traditionally been staged using CT. These areas have previously been difficult to assess with MRI, given the small structures and prohibitive imaging times. However, with improvements in both hardware and software, thin slice MR images of these areas can now be performed within a reasonable amount of time, with superior soft tissue resolution compared to CT. This allows identification of important features that affect management decisions and help direct treatment, even in recurrent disease. MRI has now become a powerful tool in the management of these neoplasms. Abstract
Laryngeal and hypopharyngeal cancers, like other head and
neck cancers, begin as mucosal lesions, and their mucosal extent is far better
assessed by clinical and endoscopy at presentation. Imaging plays a
complementary role in the clinical workup. The extent of the local tumour and
the various patterns of spread can be identified, as can the complex and
intricate anatomy of the larynx and the hypopharynx. Features which may upstage
the T staging of these tumours can be identified, and thus assist in treatment
planning. Nodal staging is also better performed with imaging, again assisting
in treatment planning.
Traditionally performed with CT, MRI now plays a greater
role in the staging of these neoplasms. The superior soft tissue resolution,
together with new hardware and software capable of achieving thin sections within
a reasonable amount of time has contributed to this paradigm shift. Cartilage
invasion in particular, one of the important criteria determining T staging of laryngeal
carcinoma is better assessed at MRI. This is less well assessed with CT, as reactive
peritumoral inflammatory change can be difficult to differentiate from actual
tumour invasion. There are some drawbacks to MRI, being more costly and
laborious and takes longer to perform, although there is no radiation burden. The
extent of submucosal spread and soft tissue invasion (e.g. paraglottic space
involvement by hypopharyngeal carcinomas, pharyngeal constrictor invasion) is
also better seen with MRI. In post-treatment cases, the soft tissue changes
induced by surgery and chemoradiotherapy (CRT) make it more difficult to
identify recurrent tumours, especially with CT. Here, the superior soft tissue
resolution in MRI plays a role in helping to identify recurrent lesions,
although this still remains challenging.
When performing MRI for the larynx and hypopharynx,
meticulous attention to technique and the use of surface coils with a small
field of view (FOV) greatly enhances the accuracy of this examination.
Pre-imaging patient preparation is important. Coaching and practicing with the
patient beforehand familiarizes the patient with the examination requirements,
with greater cooperation, resulting in better quality images. Use of thin slice
techniques is preferred. Slice planning for the T1 and T2 images should be
identical, allowing more accurate evaluation. Surface coils placed over the
larynx and hypopharynx are essential; their proximity to the small structures
of the larynx and hypopharynx ensures less signal loss and increased
conspicuity of anatomic structures. Gadolinium administration is also helpful,
although this may not be in patients with severe renal impairment. DWI
sequences can also be of use in identifying subtle tumours.
Accurate T staging of these tumours is important in
directing therapy. T1 and T2 tumours may be treated by radiotherapy (RT) or
surgery, while T3 and T4 tumours may be treated with surgery and RT, or
chemotherapy, with our without salvage surgery. Features that need to be
identified include:
• cartilage erosion
– minor (T3) vs major (T4a)
• pre-epiglottic / paraglottic invasion – T3
• extralaryngeal spread (e.g. thyroid gland) –
T4
• prevertebral invasion – T4
• carotid encasement – T4
• mediastinal involvement – T4
With regards to laryngeal invasion, the use of high-resolution
imaging with surface coils better visualizes the laryngeal cartilages,
including the small arytenoid cartilages. Accurate identification of laryngeal
cartilage invasion is important, as cartilage invasion alters staging and
prognosis, and may preclude voice-sparing surgical techniques. Extensive
cartilage invasion and extralaryngeal spread is also an unfavourable
prognosticator for radiotherapy. Normal laryngeal cartilage may be ossified or
unossified. At MRI, unossified cartilage shows low T1W signal, low T2W signal and no enhancement
post-contrast. In comparison, normal ossified cartilage shows high T1W signal, high T2W
signal and no enhancement post-contrast.
Early studies evaluating the accuracy of MRI using standard
neurovascular coils showed MRI was no better than CT at identifying cartilage
invasion. However, these examinations employed large FOVs and adopted the
following criteria to determine cartilage invasion - low T1 signal within the
cartilage, intermediate/high T2 signal within the cartilage and any enhancement.
However, with the adoption of new criteria for identifying cartilage invasion,
and the use of surface coils and a small FOV, the accuracy of MRI was
increased. Currently used imaging criteria for the evaluation of laryngeal
cartilage invasion (using the tumour as the reference structure) are:
•
Low T1
•
Inflammation: T2 & enhancement greater than tumour
•
Invasion: T2 & enhancement similar to tumour
Subtle infiltration of the pharyngeal constrictor muscles and
infiltration of the paraglottic fat, particularly by hypopharyngeal carcinomas,
is also better demonstrated. This can appear as subtle disruption and signal
change in these soft tissue structures and their presence affects the T staging
of the primary tumour. Again, the greater soft tissue resolution with MRI
allows the radiologist to better identify these features.
In the post-treatment scenario, MRI is superior to CT in
differentiating between post treatment scar and recurrent tumour, thereby
making it more useful for follow up studies. Post-treatment changes such as
Reinke’s oedema may be identified, while it is easier to differentiate
recurrent tumour from post-treatment scarring. MR-PET may also play an
important role in the future.
In conclusion, MRI plays an important role in the staging of laryngeal
and hypopharyngeal cancers. The superior soft-tissue contrast resolution,
coupled with meticulous attention to technique allows for improved anatomic and
tumour delineation, demonstration of cartilage invasion and identification of
recurrent tumours.
Acknowledgements
No acknowledgement found.References
1. Head and Neck Cancer. Multidisciplinary Management Guidelines. ENTUK - British Association of Otorhinolaryngology, Head andNeck Surgery, 4th edition, 2011
2. Becker et al. Minerva Becker, Peter Zbären, Jan Walther Casselman, Romain Kohler, Pavel Dulguerov, and Christoph D. Becker. Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging. Radiology 2008 249:2, 551-559
3. Hermans R. Imaging of hypopharyngeal and cervical oesophageal cancer. Cancer Imaging. 2004;4(1):7-9.
4. D
M Yousem,
K Gad, R P Tufano.
Resectability
issues with head and neck Cancer. AJNR
Am J Neuroradiol. 2006 Nov-Dec;27(10):2024-36.
5. Becker
M, Burkhardt K, Dulguerov
P, Allal
A. Imaging of the larynx and hypopharynx. Eur J Radiol.
Jun 2008;66(3):460-79.
6. Zbaren
P, Becker M, Lang H. Pretherapeutic
staging of laryngeal carcinoma: clinical ?ndings, computed tomography, and
magnetic resonance imaging compared with histopathology. Cancer
1996;77(7):1263–1273.
7. AJCC
Cancer staging Manual 7th edition. Edge, S.B.; Byrd, D.R.;
Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A. (Eds.). Springer 2010.
8. Recommendations
for Cross-Sectional Imaging in Cancer Management, The Royal College Of
Radiologists, Issue 2